We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

102 hedge funds and large institutions have $1.12B invested in Lexicon Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 27

10% more capital invested

Capital invested by funds: $1.02B → $1.12B (+$100M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

1% less funds holding

Funds holding: 103 → 102 (-1)

Holders
102
Holders Change
-1
Holders Change %
-0.97%
% of All Funds
3.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
37
Reduced
27
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS AM
UBS AM
Illinois
+$11.9M
2
TRSOTSOK
Teachers Retirement System of the State of Kentucky
Kentucky
+$4.86M
3
BFA
BlackRock Fund Advisors
California
+$3.45M
4
Norges Bank
Norges Bank
Norway
+$990K
5
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$686K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$4.62M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$3.64M
3
Morgan Stanley
Morgan Stanley
New York
-$2.88M
4
Franklin Resources
Franklin Resources
California
-$1.57M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
51
BlackRock Advisors
Delaware
$336K -$83.9K -5,004 -20%
VOYA Investment Management
52
VOYA Investment Management
Georgia
$330K – – –
KFC
53
Klingenstein Fields & Co
New York
$286K – – –
SNC
54
Stifel Nicolaus & Co
Missouri
$283K -$142K -8,473 -33%
ARTA
55
A.R.T. Advisors
New York
$270K – – –
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
$245K +$206K +12,307 +500%
Citigroup
57
Citigroup
New York
$244K +$202K +12,050 +463%
JP Morgan Chase
58
JP Morgan Chase
New York
$225K -$1.47M -87,814 -87%
SAA
59
Southeast Asset Advisors
Georgia
$158K – – –
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$151K -$31.9K -1,902 -17%
TD Asset Management
61
TD Asset Management
Ontario, Canada
$139K – – –
N
62
Nuveen
North Carolina
$129K +$2.87K +171 +2%
Comerica Bank
63
Comerica Bank
Texas
$123K +$10.3K +612 +9%
SG Americas Securities
64
SG Americas Securities
New York
$116K +$50.5K +3,014 +76%
Citadel Advisors
65
Citadel Advisors
Florida
$115K -$1.03M -61,629 -90%
Public Employees Retirement Association of Colorado
66
Public Employees Retirement Association of Colorado
Colorado
$112K – – –
U
67
UBS
Switzerland
$110K +$63.8K +3,805 +135%
RG
68
Rathbones Group
United Kingdom
$105K – – –
VKH
69
Virtu KCG Holdings
New York
$101K +$102K +6,090 New
Teacher Retirement System of Texas
70
Teacher Retirement System of Texas
Texas
$68K +$30.7K +1,828 +81%
LTFS
71
Ladenburg Thalmann Financial Services
Florida
$60K – – –
Jane Street
72
Jane Street
New York
$60K +$60.4K +3,599 New
CAM
73
Capstone Asset Management
Texas
$56K – – –
BBA
74
BLB&B Advisors
Pennsylvania
$55K – – –
TTWM
75
TCV Trust & Wealth Management
Virginia
$55K – – –
1 2
3
4 5

LXRX Hedge Fund Activity: Q3 2013 in Review

102 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q3 2013, worth a combined $1.12B — up 9.9% from $1.02B a quarter earlier.

Fund positioning in LXRX was balanced in Q3 2013: 8 funds opened new positions, 8 closed out, 37 added to existing stakes and 27 trimmed.

The largest buyer was UBS AM, adding an estimated $11.9M. The largest seller was Vanguard Group, cutting an estimated $4.62M.

  • 102 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q3 2013, down from 103 in Q2 2013.
  • Funds reported $1.12B of Lexicon Pharmaceuticals stock for Q3 2013, up 9.9% quarter-over-quarter.
  • 8 funds opened new Lexicon Pharmaceuticals positions in Q3 2013 and 8 closed out, a net change of 0 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q3 2013 was UBS AM, an estimated $11.9M added.
  • The largest Lexicon Pharmaceuticals seller in Q3 2013 was Vanguard Group, an estimated $4.62M sold.

Based on aggregated 13F filings for Q3 2013.